Altered heme pathway regulation and drug metabolizing enzyme system in a mouse model of hepatocarcinogenesis: Effect of veronal

1. Male CF 1 mice were fed p-dimethylaminoazobenzene (DAB) for 35 days and received 5,5 diethylbarbituric acid, before or after DAB treatment, with the purpose of investigating whether the onset of the preinitiation stage of carcinogenesis alters the natural regulatory mechanism of the heme pathway....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Gerez, E.
Otros Autores: Vazquez, E., Caballero, F., Polo, C., Batlle, A.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1997
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 09258caa a22009737a 4500
001 PAPER-3174
003 AR-BaUEN
005 20230518203238.0
008 190411s1997 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0030879634 
024 7 |2 cas  |a 4 dimethylaminoazobenzene, 60-11-7; 5 aminolevulinate synthase, 9037-14-3; barbital, 144-02-5, 57-44-3; cytochrome P450, 9035-51-2; heme oxygenase, 9059-22-7 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a GEPHD 
100 1 |a Gerez, E. 
245 1 0 |a Altered heme pathway regulation and drug metabolizing enzyme system in a mouse model of hepatocarcinogenesis: Effect of veronal 
260 |c 1997 
270 1 0 |m Batlle, A.Viamonte 1881 10 'A', 1056 Beunos Aires, Argentina 
506 |2 openaire  |e Política editorial 
504 |a Aström, A., De Pierre, J., Eriksson, L., Characterization of drug metabolizing systems in hyper-plastic nodules from the livers of rats receiving 2-acetylaminofluorene in their diet (1983) Carcinogenesis (Lond.), 4, pp. 577-581 
504 |a Brady, A., Hasmall, R., Elcombe, B., Comparison of the effects of griseofulvin and dihydropyridines on ferrochelatase mouse and rat hepatocytes (1993) Toxicol. in Vitro, 7, pp. 587-593 
504 |a Cameron, R., Sweeney, G., Jones, K., Lee, G., Farber, E., A relative deficiency of cytochrome P450 and aryl hydrocarbonbenzo (α) pyrene hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver (1976) Cancer Res., 36, pp. 3888-3893 
504 |a Chance, B., Maehly, A., Assay of catalases and peroxidases (1955) Methods in Enzymology Vol. 2, pp. 764-768. , E. Chance, & A. Maehly. New York: Academic Press 
504 |a El-Mouelhi, M., Didolkar, M., Elias, E., Guengerich, F., Kauffman, F., Hepatic drug metabolizing enzymes in primary and secondary tumors of human liver (1987) Cancer Res., 47, pp. 460-466 
504 |a Farber, E., Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A. Clowes Memorial Lectures (1984) Cancer Res., 44, pp. 5463-5474 
504 |a Gindi, T., Ghazarian, D., Deitch, D., Farber, E., An origin of presumptive preneoplastic foci and nodules from hepatocytes in chemical carcinogenesis in rat liver (1994) Cancer Lett., 83, pp. 75-80 
504 |a Habib, S., Srikanth, N., Scappaticci, F., Faletto, M., MacCulbin, A., Farber, E., Ghoshal, A., Gurtoo, H., Altered expression of cytochrome P450 mRNA during chemical-induced hepatocarcinogenesis and following partial hepatectomy (1994) Toxicol. Appl. Pharmacol., 124, pp. 139-148 
504 |a Habig, W., Pabst, M., Jakoby, W., Glutathione-S-transferases: The first enzymatic step in mercapturic acid formation (1974) J. Biol. Chem., 249, pp. 7130-7139 
504 |a Harrison, D., Molecular mechanism of drug resistance in tumors (1995) J. Pathol., 175, pp. 7-12 
504 |a Kanduc, D., Aresta, A., Farber, E., Hyper-methylation of replicating hepatic DNA following N-methyl-N-nitrosourea administration (1994) Int. J. Cancer, 58, pp. 436-439 
504 |a Kitagawa, T., Pitot, H., Miller, E., Miller, J., Promotion by dietary phenobarbital of hepatocarcinogenesis by 2-methyl-N,N-dimethyl-4-aminoazobenzene in the rat (1979) Cancer Res., 39, pp. 112-115 
504 |a Knox, W., L-Tryptophan 2,3-dioxygenase (trytophanpyrrolase) (rat liver) (1970) Methods Enzymol., 17, pp. 415-417 
504 |a Lowry, O., Rosebrough, N., Farr, A., Randall, R., Protein measurement with the Folin-phenol reagent (1951) J. Biol Chem., 193, pp. 265-275 
504 |a Marver, H., Tschudy, D., Perlroth, M., Collins, A., δ-Aminolevulinic acid synthetase I: Studies in liver homogenates (1966) J. Biol. Chem., 241, pp. 2803-2809 
504 |a Miller, E., Miller, J., The metabolism of chemical carcinogens to reactive electrophiles and their possible mechanism of action in carcinogenesis (1976) Chemical Carcinogens, pp. 737-762. , C.E. Searle. Washington DC: American Chemical Society 
504 |a Omura, T., Sato, R., The carbon monoxide binding pigment of liver microsomes (1964) J. Biol. Chem., 239, pp. 2370-2378 
504 |a Peraino, C., Fry, R., Staffeldt, E., Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene (1971) Cancer Res., 31, pp. 1506-1512 
504 |a Polo, C., Vazquez, E., Caballero, F., Gerez, E., Batlle, A., Heme biosynthesis pathway regulation in a model of hepatocarcinogenesis pre-initiation (1992) Comp. Biochem. Physiol., 103, pp. 251-256 
504 |a Salonpää, P., Krause, K., Pelkonen, O., Up-regulation of CyP2A5 expression by porphyrinogenic agents in mouse liver (1995) Naunyn-Schmideberg's Arch. Pharmac., 351, pp. 446-452 
504 |a Stout, D., Becker, F., Alteration of the ability of liver microsomes to activate N-2-fluorencylacetamide to mutagen of Salmonella thypimurium during hepatocarcinogenesis (1978) Cancer Res., 38, pp. 2274-2278 
504 |a Stout, D., Becker, F., Heme enzyme pattern in rat liver nodules and tumors (1987) Cancer Res., 47, pp. 963-966 
504 |a Tatematsu, M., Tsuda, H., Shibata, M., Masui, T., Asamoto, S., Ito, N., Placental type of glutathione S-transferase (GST-P) as a new marker for hepatocarcinogenesis (1986) Proc. Am. Assoc. Cancer Res. Abstracts, 27, p. 100 
504 |a Toyokuni, S., Okamoto, K., Yodoi, J., Hiai, H., Persistent oxidative stress in cancer (1995) FEBS Letters, 358, pp. 1-3 
504 |a Tredaniel, J., Zalcman, G., Douriez, E., Genes and enzymes involved in carcinogen metabolism (1995) Bull. Cancer, 82, pp. 77-S84 
504 |a Waxman, D., Azaroff, L., Phenobarbital induction of cytochrome P450 gene expression (1992) Biochem. J., 281, pp. 577-592 
504 |a Yoshida, T., Kikuchi, G., Purification and properties of heme oxygenase from pig spleen microsomes (1978) J. Biol. Chem., 253, pp. 4224-4229 
520 3 |a 1. Male CF 1 mice were fed p-dimethylaminoazobenzene (DAB) for 35 days and received 5,5 diethylbarbituric acid, before or after DAB treatment, with the purpose of investigating whether the onset of the preinitiation stage of carcinogenesis alters the natural regulatory mechanism of the heme pathway. 2. Changes detected in drug metabolizing enzymes are likely to be the consequence of a primary deregulation mechanism of heme metabolism, shown by an increase in 6 aminolevulinic acid synthetase activity and a decrease in microsomal heme oxygenase, which would finally lead to a great enhancement of cytochrome P450 levels. 3. The alterations found here would give rise to a pattern distinctive to that usually observed in the so called resistant hepatocyte.  |l eng 
536 |a Detalles de la financiación: Universidad de Buenos Aires 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas 
536 |a Detalles de la financiación: Ministerio de Educación y Cultura 
536 |a Detalles de la financiación: A. M. del C. Batlle and E. Vazquez hold the posts of Superior and Associate Scientific Researchers and E. Gerez and F. Caballero hold the posts of Researcher Assistant at the Argentine National Research Council (CONICET). The support of CONICET, the University of Buenos Aires and the Ministerio de Educación y Ciencia of Spain is gratefully acknowledged. A. M. del C. Batlle is also grateful to the Association for International Cancer Research (AICR), United Kingdom, for special help. We are indebted to Mrs. Beatriz Corvalán for her skilled technical assistance. To the memory of our beloved César. 
593 |a Ctro. Invest. Sobre Porfirinas Y P., (CONICET-FCEN, UBA), Cd. Univ., Buenos Aires, Argentina 
690 1 0 |a AZO-DYE 
690 1 0 |a DRUG METABOLIZING ENZYME SYSTEM 
690 1 0 |a HEME METABOLISM 
690 1 0 |a HEPATOCARCINOGENESIS 
690 1 0 |a PORPHYRINOGEN DRUG 
690 1 0 |a 4 DIMETHYLAMINOAZOBENZENE 
690 1 0 |a 5 AMINOLEVULINATE SYNTHASE 
690 1 0 |a BARBITAL 
690 1 0 |a CYTOCHROME P450 
690 1 0 |a HEME OXYGENASE 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ANIMAL TISSUE 
690 1 0 |a ARTICLE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a ENZYME ACTIVITY 
690 1 0 |a HEME SYNTHESIS 
690 1 0 |a LIVER CARCINOGENESIS 
690 1 0 |a MALE 
690 1 0 |a MOUSE 
690 1 0 |a NONHUMAN 
690 1 0 |a PRIORITY JOURNAL 
700 1 |a Vazquez, E. 
700 1 |a Caballero, F. 
700 1 |a Polo, C. 
700 1 |a Batlle, A. 
773 0 |d 1997  |g v. 29  |h pp. 569-573  |k n. 4  |p GEN. PHARMACOL.  |x 03063623  |w (AR-BaUEN)CENRE-4808  |t General Pharmacology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030879634&doi=10.1016%2fS0306-3623%2896%2900574-5&partnerID=40&md5=460642344f699bcef18a28906b5ef71c  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/S0306-3623(96)00574-5  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_03063623_v29_n4_p569_Gerez  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03063623_v29_n4_p569_Gerez  |y Registro en la Biblioteca Digital 
961 |a paper_03063623_v29_n4_p569_Gerez  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 64127